FrancophonIA/ELRC3.0 huggingface dataset:
English: Eye disorders miosis, visual acuity reduced uncommon
Danish: Myosis, nedsat synsskarphed
English: It should be noted that systemic exposure in adult male rats was lower than the therapeutic exposure in humans at 40 mg. Consequently, no adequate assessment of potential effects on male fertility in rats can be made.
Danish: Det bør bemærkes, at systemisk eksponering til voksne hanrotter var lavere end terapeutisk eksponering til mennesker ved 40 mg.
English: Alternative non-hormonal back-up methods of contraception should be used during treatment with EMEND and for 2 months following the last dose of EMEND (see section 4.5).
Danish: Alternative ikke-hormonale back-up kontraceptionsmetoder bør anvendes under behandling med EMEND og i 2 måneder efter den sidste EMEND-dosis (se pkt.
English: Capsules are opaque with a light blue cap and a white body with “466” and “165 mg” printed radially in black ink on one side of the body and the Merck logo on the other side.
Danish: Kapslerne er ugennemsigtige med lyseblå kappe og en hvid kerne med "466" og "165 mg" præget med sort blæk på den ene side af kapslen og Merck-logoet på den anden side.
English: Table 3 Percent of adult patients responding by treatment group and phase for Study 2 - Cycle 1 Moderately Emetogenic Chemotherapy
Danish: Tabel 3 Procent voksne patienter, som responderer pr. behandlingsgruppe og -fase i undersøgelse 2 - cyklus 1 Moderat emetogen kemoterapi
English: As a moderate inhibitor of CYP3A4, aprepitant (125 mg/80 mg) can increase plasma concentrations of co-administered active substances that are metabolised through CYP3A4.
Danish: Som en moderat hæmmer af CYP3A4 kan aprepitant (125 mg/80 mg) øge plasmakoncentrationen af samtidigt administrerede aktive substanser, som metaboliseres gennem CYP3A4.
English: Uncommon side effects (may affect up to 1 in 100 people) are: - upper stomach pain, bowel sounds abnormal, dry mouth, nausea, stomach discomfort, serious constipation, small bowel not working properly (sub-ileus), - decreased feeling or sensitivity (especially in skin), sensory disturbance, difficulty in speaking, - decrease in pupil size, decrease in sharpness of vision (vision loss), - inability to sleep, - slow heartbeat, - whistling sound while breathing, shortness of breath.
Danish: Ikke almindelige bivirkninger (kan berøre op til 1 ud af 100 personer): - Smerter i øverste del af maven, unormale tarmlyde, mundtørhed, kvalme, mavebesvær, alvorlig forstoppelse, dårlig tarmfunktion (sub-ileus) - Nedsat følelse eller følsomhed (især i huden), føleforstyrrelser, talebesvær - Formindsket pupilstørrelse, nedsat synsskarphed (tab af syn) - Søvnbesvær - Langsom hjerterytme (puls) - Hvæsende vejrtrækning, åndenød.
English: PARTICULARS TO APPEAR ON THE SMALL IMMEDIATE PACKAGING
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN INDRE EMBALLAGE
English: In patients on chronic warfarin therapy, the prothrombin time (INR) should be monitored closely during treatment with EMEND and for 2 weeks following each 3-day course of EMEND for chemotherapy induced nausea and vomiting (see section 4.4).
Danish: Hos patienter i kronisk warfarinbehandling bør prothrombintiden (INR) overvåges nøje under behandling med EMEND og i 2 uger efter hvert 3-dages behandlingsregime med EMEND til kvalme og opkastning forårsaget af kemoterapi (se pkt.
English: Musculoskeletal and connective tissue disorders muscular weakness, muscle spasms rare
Danish: Muskelsvækkelse, muskelkramper
English: EMEND contains the active substance aprepitant and belongs to a group of medicines called "neurokinin 1 (NK1) receptor antagonists".
Danish: EMEND indeholder det aktive stof aprepitant og tilhører en gruppe af lægemidler, der kaldes "neurokinin 1 (NK1) receptorantagonister".
English: In animal studies there was no indication of direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3).
Danish: I dyreforsøg var der ingen indikation af direkte eller indirekte skadelige virkninger med hensyn til graviditet, embryonal/føtal udvikling, fødsel eller postnatal udvikling (se pkt.
English: This effect was not considered clinically important.
Danish: Denne virkning blev ikke anset for at være klinisk signifikant.
English: Titanium dioxide (E 171) Red iron oxide (E 172) Yellow iron oxide (E 172)
Danish: Titandioxid (E171) Rød jernoxid (E172) Gul jernoxid (E172)
English: Each capsule contains 40 mg of aprepitant.
Danish: Hver kapsel indeholder 40 mg aprepitant.
English: When a single 375 mg dose of aprepitant was administered on Day 9 of a 14-day regimen of 600 mg/day of rifampicin, a strong CYP3A4 inducer, the AUC of aprepitant decreased 91 % and the mean terminal half-life decreased 68 %.
Danish: Når en enkelt 375 mg dosis aprepitant blev administreret på dag 9 i et 14-dages behandlingsregime med 600 mg/dag rifampicin, der er en stærk CYP3A4-inducer, faldt aprepitants AUC med 91%, og gennemsnitshalveringstiden faldt med 68%.
English: Each capsule contains 165 mg of aprepitant.
Danish: Hver kapsel indeholder 165 mg aprepitant.
English: As a moderate inhibitor of CYP3A4, aprepitant can increase plasma concentrations of co-administered active substances that are metabolised through CYP3A4.
Danish: Som en moderat hæmmer af CYP3A4 kan aprepitant øge plasmakoncentrationen af samtidigt administrerede aktive substanser, som metaboliseres gennem CYP3A4.
English: • The oral suspension can be kept at room temperature (not above 30°C) for up to 3 hours, prior to administration.
Danish: • Den orale suspension kan opbevares ved almindelig temperatur (højst 30 °C) i op til 3 timer før anvendelse.
English: Common side effects (may affect up to 1 in 10 people) are: - constipation, indigestion, - headache, - tiredness, - loss of appetite, - hiccups, - increased amount of liver enzymes in your blood.
Danish: Almindelige bivirkninger (kan berøre op til 1 ud af 10 personer): - Forstoppelse, fordøjelsesbesvær - Hovedpine - Træthed - Appetitløshed - Hikke - Stigning i antal leverenzymer i blodet.
English: Aluminium blister containing one 165 mg capsule.
Danish: Aluminiumblister med en 165 mg kapsel.
English: Aluminium blister containing one 40 mg capsule.
Danish: Aluminiumsblister indeholdende 1 stk. 40 mg kapsel.
English: EMEND may be taken with or without food.
Danish: EMEND kan tages med eller uden mad.
English: EMEND, when given as a regimen of 125 mg with dexamethasone co-administered orally as 20 mg on Day 1, and EMEND when given as 80 mg/day with dexamethasone co-administered orally as 8 mg on Days 2 through 5, increased the AUC of dexamethasone, a CYP3A4 substrate, 2.2-fold on Days 1 and 5.
Danish: Når EMEND blev administreret som et behandlingsregime med 125 mg administreret samtidig med 20 mg dexamethason oralt på dag 1, og EMEND administreret som 80 mg/dag med dexamethason 8 mg indgivet samtidig oralt på dag 2 til 5, forhøjedes AUC for dexamethason, et CYP3A4-substrat, 2,2 gange på dag 1 og 5.
English: During treatment with EMEND, CYP3A4 is inhibited for up to 4 days.
Danish: CYP3A4 hæmmes i op til 4 dage under behandling med EMEND.
English: Each hard capsule contains 165 mg of aprepitant.
Danish: Hver hård kapsel indeholder 165 mg aprepitant.
English: Aluminium blister containing two 80 mg capsules.
Danish: Aluminiumblister med 2 stk. 80 mg kapsler.
English: Warnings and precautions Talk to your doctor, pharmacist, or nurse before taking EMEND.
Danish: Advarsler og forsigtighedsregler Kontakt lægen, apotekspersonalet eller sundhedspersonalet, før du tager EMEND.
English: As a weak inhibitor of CYP3A4, aprepitant (40 mg) can increase plasma concentrations of orally co-administered active substances that are metabolised through CYP3A4.
Danish: Som en svag hæmmer af CYP3A4 kan aprepitant (40 mg) øge plasmakoncentrationen af samtidigt oralt administrerede aktive substanser, som metaboliseres gennem CYP3A4.
English: Psychiatric disorders anxiety uncommon disorientation, euphoric mood rare
Danish: Desorientering, euforisk stemning
English: The recommended oral dose of EMEND is Day 1: - one 125 mg capsule 1 hour before you start your chemotherapy session and
Danish: Dag 1: - En 125 mg kapsel 1 time før du starter på kemoterapibehandlingen og
English: Each 80 mg hard capsule contains 80 mg of aprepitant.
Danish: Hver 80 mg hård kapsel indeholder 80 mg aprepitant.
English: Each 80 mg capsule contains 80 mg of aprepitant.
Danish: Hver 80 mg kapsel indeholder 80 mg aprepitant.
English: OUTER CARTON EMEND 125 mg powder for oral suspension
Danish: YDRE KARTON EMEND 125 mg pulver til oral suspension
English: PRIMARY ENDPOINT Complete response
Danish: PRIMÆRT ENDEPUNKT Komplet respons
English: AST increased, blood alkaline phosphatase increased uncommon red blood cells urine positive, blood sodium decreased, weight decreased, neutrophil count decreased, glucose urine present, urine output increased rare
Danish: Positiv test for røde blodceller i urinen, fald i natrium i blodet, vægttab, fald i neutrofiltal, glucose i urinen, øget diurese
English: The following adverse reactions were observed in a pooled analysis of the HEC and MEC studies at a greater incidence with aprepitant than with standard therapy or in postmarketing use.
Danish: Følgende bivirkninger blev observeret i en poolet analyse af HEC- og MEC-studier med en højere incidens med aprepitant end med standardbehandling eller ved anvendelse efter markedsføring.
English: EMEND 125 mg hard capsules Aprepitant
Danish: EMEND 125 mg hårde kapsler aprepitant
English: EMEND 125 mg hard capsules EMEND 80 mg hard capsules aprepitant
Danish: EMEND 125 mg hårde kapsler EMEND 80 mg hårde kapsler aprepitant
English: Frequency disorders photosensitivity reaction, hyperhidrosis, seborrhoea, skin lesion, rash pruritic, Stevens-Johnson syndrome/toxic epidermal necrolysis rare pruritus, urticaria not known
Danish: Lysfølsomhedsreaktion, hyperhidrose, seborré, hudlæsioner, kløende udslæt, Stevens-Johnsons syndrom/toksisk epidermal nekrolyse
English: Excipient with known effect Each capsule contains 40 mg of sucrose.
Danish: Hjælpestof, som behandleren skal være opmærksom på Hver kapsel indeholder 40 mg saccharose.
English: Each hard capsule contains 40 mg of aprepitant.
Danish: Hver hård kapsel indeholder 40 mg aprepitant.
English: The other ingredients are: sucrose, microcrystalline cellulose (E 460), hydroxypropylcellulose (E 463), sodium laurilsulfate, gelatin, titanium dioxide (E 171), Indigo carmine (E 132), shellac, potassium hydroxide, and black iron oxide (E 172).
Danish: - Øvrige indholdsstoffer: Saccharose, mikrokrystallinsk cellulose (E460), hydroxypropylcellulose (E463), natriumlaurilsulfat, gelatine, titandioxid (E171), indigocarmin (E132), shellac, kaliumhydroxid og sort jernoxid (E172).
English: 5 Aluminium blisters each containing one 40 mg capsule.
Danish: 5 aluminiumsblistre hver indeholdende 1 stk. 40 mg kapsel.
English: EMEND 80 mg hard capsules Aprepitant
Danish: EMEND 80 mg hårde kapsler aprepitant
English: Excipient with known effect Each capsule contains 165 mg of sucrose.
Danish: Hjælpestof, som behandleren skal være opmærksom på Hver kapsel indeholder 165 mg saccharose.
English: EMEND 165 mg hard capsules
Danish: EMEND 165 mg hårde kapsler
English: Table 2 Percent of adult patients responding by treatment group and phase - Cycle 1 Moderately Emetogenic Chemotherapy
Danish: Tabel 2 Procent voksne patienter, som responderer pr. behandlingsgruppe og fase - cyklus 1 Moderat emetogen kemoterapibehandling
English: When a single 125 mg dose of aprepitant was administered on Day 5 of a 10-day regimen of 400 mg/day of ketoconazole, a strong CYP3A4 inhibitor, the AUC of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold.
Danish: Når en enkelt 125 mg dosis aprepitant blev administreret på dag 5 af et 10-dages behandlingsregime med 400 mg/dag ketoconazol, der er en stærk CYP3A4-hæmmer, steg aprepitants AUC ca. 5 gange og aprepitants gennemsnitshalveringstid steg ca. 3 gange.
English: EMEND may have minor influence on the ability to drive, cycle and use machines.
Danish: EMEND kan have en mindre indvirkning på evnen til at køre bil, cykle og betjene maskiner.
English: During treatment with EMEND, CYP3A4 is inhibited.
Danish: CYP3A4 hæmmes under behandling med EMEND.
English: Warnings and precautions Talk to the doctor, pharmacist, or nurse before you take EMEND or give this medicine to the child.
Danish: Kontakt lægen, apotekspersonalet eller sundhedspersonalet, før du tager EMEND eller giver lægemidlet til barnet.
English: This is not considered to be clinically important.
Danish: Dette anses ikke for at være klinisk relevant.
English: Effect of other medicinal products on the pharmacokinetics of aprepitant Concomitant administration of EMEND with active substances that inhibit CYP3A4 activity (e.g., ketoconazole, itraconazole, voriconazole, posaconazole, clarithromycin, telithromycin, nefazodone, and protease inhibitors) should be approached cautiously, as the combination is expected to result in several-fold increased plasma concentrations of aprepitant (see section 4.4).
Danish: Andre lægemidlers virkning på aprepitants farmakokinetik Samtidig administration af EMEND og aktive substanser, som hæmmer CYP3A4-aktivitet (fx ketoconazol, itraconazol, voriconazol, posaconazol, clarithromycin, telithromycin, nefazodon og proteasehæmmere), bør kun ske med forsigtighed, idet kombinationen forventes at medføre mangedobbelt forhøjede plasmakoncentrationer af aprepitant (se pkt.
English: Additional adverse reactions were observed in adult patients treated with aprepitant for postoperative nausea and vomiting (PONV) and a greater incidence than with ondansetron: abdominal pain upper, bowel sounds abnormal, constipation*, dysarthria, dyspnoea, hypoaesthesia, insomnia, miosis, nausea, sensory disturbance, stomach discomfort, sub-ileus*, visual acuity reduced, wheezing.
Danish: Der blev observeret yderligere bivirkninger hos voksne patienter, som blev behandlet med aprepitant mod postoperativ kvalme og opkastning (PONV) og med højere incidens end for ondansetron: Smerter i øvre del af abdomen, anormale tarmlyde, obstipation*, dysartri, dyspnø, hypoæstesi, søvnløshed, myosis, kvalme, sensoriske forstyrrelser, mavegener, sub-ileus*, nedsat synsskarphed, hvæsende vejrtrækning.
English: Each 125 mg hard capsule contains 125 mg of aprepitant.
Danish: Hver 125 mg hård kapsel indeholder 125 mg aprepitant.
English: Figure 1 Percent of adult patients receiving Highly Emetogenic Chemotherapy who remain emesis free over time - Cycle 1
Danish: Figur 1 Procent voksne patienter, som forbliver opkastningsfrie over tid - cyklus 1 Højemetogen kemoterapibehandling
English: The 125 mg capsule is opaque with a white body and pink cap with “462” and “125 mg” printed radially in black ink on the body.
Danish: 125 mg kapslen er ugennemsigtig med hvid kerne og lyserød kappe med "462" og "125 mg" præget med sort blæk på kapslen.
English: Another or additional non-hormonal form of birth control should be used during treatment with EMEND and for up to 2 months after using EMEND,
Danish: Du skal anvende et andet eller et supplerende ikke-hormonalt graviditetsforebyggende middel under behandling med EMEND og i op til 2 måneder efter, du har taget EMEND.
English: EMEND contains the active substance aprepitant and belongs to a group of medicines called "neurokinin 1 (NK1) receptor antagonists" (antiemetics and antinauseants).
Danish: EMEND indeholder det aktive stof aprepitant og tilhører en gruppe lægemidler, der kaldes ”neurokinin 1 (NK1) receptorantagonister” (antiemetika).
English: After reconstitution, 1 mL oral suspension contains 25 mg of aprepitant - The other ingredients are: hydroxypropyl-cellulose (E 463), sodium laurilsulfate (E 487), sucrose and lactose (see section 2 under ‘EMEND contains sucrose and lactose'), red iron oxide (E 172) and sodium stearyl fumarate (E 485).
Danish: - Øvrige indholdsstoffer: hydroxypropylcellulose (E463), natriumlaurilsulfat (E487), saccharose og lactose (se punkt 2 under “EMEND indeholder saccharose og lactose”), rød jernoxid (E172) og natriumstearylfumarat (E485).
English: If the child could not take the whole dose, call the child's healthcare provider.
Danish: Kontakt barnets læge eller sundhedspersonale, hvis barnet ikke kunne tage hele dosen.
English: EMEND 165 mg hard capsules are supplied in cartons in the following pack sizes: - Aluminium blister containing one 165 mg capsule - 6 Aluminium blisters each containing one 165 mg capsule
Danish: - Aluminiumblister med en 165 mg kapsel - 6 stk. aluminiumblistre hver indeholdende1 stk. 165 mg kapsel.
English: These studies did not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3).
Danish: Disse undersøgelser indikerer hverken direkte eller indirekte skadelige virkninger med hensyn til graviditet, embryonal-/føtaludvikling, fødsel eller postnatal udvikling (se pkt.
English: If you give more EMEND than you should
Danish: Hvis du har givet for meget EMEND
English: 500-1,500 mg/m 2 and doxorubicin (< 60 mg/m 2) or epirubicin (< 100 mg/m 2), aprepitant in combination with an ondansetron/dexamethasone regimen (see section 4.2) was compared with standard therapy (placebo plus ondansetron 8 mg orally (twice on Day 1, and every 12 hours on Days 2 and 3) plus dexamethasone 20 mg orally on Day 1).
Danish: 500-1500 mg/m 2 og doxorubicin (≤ 60 mg/m 2) eller epirubicin (≤ 100 mg/m 2), blev aprepitant i kombination med et ondansetron/dexamethason behandlingsregime (se pkt.
English: EMEND, when given as a regimen of 125 mg on Day 1 and 80 mg/day on Days 2 and 3, increased the AUC of methylprednisolone, a CYP3A4 substrate, by 1.3-fold on Day 1 and by 2.5-fold on Day 3, when methylprednisolone was co-administered intravenously as 125 mg on Day 1 and orally as 40 mg on Days 2 and 3.
Danish: Når EMEND blev givet som et regime på 125 mg på dag 1 og 80 mg/dag på dag 2 og 3, steg methylprednisolons AUC, et CYP3A4substrat, med 1,3 gange på dag 1 og 2,5 gange på dag 3, når methylprednisolon blev administreret samtidigt i.v.
English: Additional adverse reactions were observed in patients treated with aprepitant for postoperative nausea and vomiting (PONV) and a greater incidence than with ondansetron: abdominal pain upper, bowel sounds abnormal, constipation*, dysarthria, dyspnoea, hypoaesthesia, insomnia, miosis, nausea, sensory disturbance, stomach discomfort, sub-ileus*, visual acuity reduced, wheezing.
Danish: Der sås yderligere bivirkninger hos patienter, som blev behandlet med aprepitant mod postoperativ kvalme og opkastning (PONV) og med højere incidens end for ondansetron: smerter i øvre del af abdomen, anormale tarmlyde, obstipation*, dysartri, dyspnø, hypæstesi, søvnløshed, myosis, kvalme, sensoriske forstyrrelser, mavegener, subileus*, nedsat synsskarphed, hvæsende vejrtrækning.
English: Concomitant administration of EMEND with herbal preparations containing St. John's Wort (Hypericum perforatum) is not recommended.
Danish: EMEND og naturlægemidler med perikon (Hypericum perforatum) bør ikke administreres samtidigt.
English: Inhibition of CYP3A4 by aprepitant could result in elevated plasma concentrations of these active substances, potentially causing serious reactions.
Danish: Aprepitants hæmning af CYP3A4 kan resultere i forhøjede plasmakoncentrationer af disse aktive substanser, hvilket potentielt kan frembringe alvorlige reaktioner.
English: What EMEND contains - The active substance is aprepitant.
Danish: EMEND indeholder: - Aktivt stof: aprepitant.
English: The potential for reproductive toxicity of aprepitant has not been fully characterised, since exposure levels above the therapeutic exposure in humans at the 125 mg/80 mg dose could not be attained in animal studies.
Danish: Risikoen for reproduktionstoksicitet på grund af aprepitant er ikke tilstrækkeligt belyst, idet der i dyreundersøgelser ikke kunne opnås resultater for eksponering over terapeutiske doser til mennesker med 125 mg/80 mg dosering.
English: A summary of the key study results are shown in Table 4.
Danish: En opsummering af nøgleresultaterne i studierne fremgår af tabel 4.
English: Tell the doctor or pharmacist if you or the child are taking, have recently taken, or might take any other medicines.
Danish: Fortæl det altid til lægen eller apotekspersonalet, hvis du eller barnet bruger anden medicin eller har brugt det for nylig.
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.
Danish: Du kan finde yderligere information om dette lægemiddel på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu.
English: EMEND 40 mg hard capsules aprepitant
Danish: EMEND 40 mg hårde kapsler aprepitant
English: The total exposure of orally administered CYP3A4 substrates may increase up to approximately 1.5-fold after a single 40 mg dose of aprepitant; the effect of aprepitant on the plasma concentrations of intravenously administered CYP3A4 substrates is expected to be smaller.
Danish: Den totale eksponering for oralt administrerede CYP3A4-substrater kan øges op til ca. 1,5 gange efter en enkelt 40 mg aprepitantdosis.
English: Aprepitant should be used with caution in these patients (see sections 4.4 and 5.2).
Danish: Aprepitant bør anvendes med forsigtighed hos disse patienter (se pkt.
English: When a single 125 mg dose of EMEND was administered on Day 1 and 80 mg/day on Days 2 and 3 to healthy subjects who were stabilised on chronic warfarin therapy, there was no effect of EMEND on the plasma AUC of R(+) or S(-) warfarin determined on Day 3; however, there was a 34 % decrease in S(-) warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14 % decrease in INR 5 days after completion of treatment with EMEND.
Danish: Når en enkelt dosis EMEND 125 mg administreredes på dag 1 og 80 mg/dag på dag 2 og 3 til raske personer, som var stabiliseret på kronisk warfarinbehandling, var der ikke virkning af EMEND på plasma AUC for R(+) eller S(-)warfarin bestemt på dag 3; der var imidlertid et 34 % fald i S(-)warfarins (et CYP2C9 substrat) dalkoncentration fulgt af et 14 % fald i INR 5 dage efter afsluttet behandling med EMEND.
English: The following adverse reactions were observed in a pooled analysis of the HEC and MEC studies at a greater incidence with aprepitant than with standard therapy in adults or postmarketing use:
Danish: Følgende bivirkninger blev observeret i en poolet analyse af HEC- og MEC-studier med højere incidens ved aprepitant end ved standardbehandling hos voksne eller ved anvendelse efter markedsføring:
English: As a mild inducer of CYP2C9, CYP3A4 and glucuronidation, aprepitant can decrease plasma concentrations of substrates eliminated by these routes within two weeks following initiation of treatment.
Danish: Som en mild inducer af CYP2C9, CYP3A4 og glukuronidering kan aprepitant nedsætte plasmakoncentrationen af de substrater, der elimineres af disse inden for to uger efter behandlingsstart.
English: EMEND 125 mg powder for oral suspension Aprepitant
Danish: EMEND 125 mg pulver til oral suspension aprepitant
English: Warnings and precautions Talk to your doctor, pharmacist, or nurse before taking this medicine.
Danish: Advarsler og forsigtighedsregler Kontakt lægen, apotekspersonalet eller sundhedspersonalet, før du tager dette lægemiddel.
English: Aluminium blister containing one 125 mg capsule.
Danish: Aluminiumblister med 1 stk. 125 mg kapsel.
English: D.
Danish: C]
English: Inhibition of CYP3A4 by aprepitant could result in elevated plasma concentrations of these active substances, potentially causing serious or life-threatening reactions.
Danish: Aprepitants hæmning af CYP3A4 kan resultere i forhøjet plasmakoncentration af disse aktive substanser, hvilket kan medføre potentielt alvorlige eller livstruende reaktioner.
English: Check with the doctor, pharmacist or nurse if you are not sure.
Danish: Spørg lægen, apotekspersonalet eller sundhedspersonalet, hvis der er noget, du er i tvivl om.
English: Each 125 mg capsule contains 125 mg of aprepitant.
Danish: Hver 125 mg kapsel indeholder 125 mg aprepitant.